Latest news
Huonslab Announces Applicable SC delivery for Antibodies and ADCs with ‘HyDIFFUZE™ Platform’ - natlawreview.comnatlawreview.com · Tue, 04 Aug 2026 01:15:36 GMTHuonslab Secures Patent for ADC Subcutaneous Formulation Incorporating ‘HyDIFFUZE™’ Platform - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTHuonslab patents ADC injection platform - Korea JoongAng DailyKorea JoongAng Daily · Mon, 27 Jul 2026 07:00:00 GMTHuonslab targets subcutaneous ADC market with new patent - koreabiomed.comkoreabiomed.com · Mon, 27 Jul 2026 04:31:11 GMT